ASNC2018Annual Scientific Session

September 6-9, 2018 San Francisco, CaliforniaSan Francisco Marriott Marquis

American Society of Nuclear Cardiology

BRIDGING QUALITY IMAGINGAND PATIENT CARE

Personalized. Real World. Collaborative.

ASNC

25th Anniversary

PRELIMINARY PROGRAM

You Now Have More Options When it Comes to Cardiac PET ImagingRUBY-FILL Generators and Elution Systems are backed by:

• 7 years of proven clinical experience• Over 35,000 patients imaged world-wide• A robust U.S. distribution channel• Experienced clinical applications and service support

RUBY-FILL is available today to meet your unique cardiac PET imaging needs. With advanced features and user-friendly technology, RUBY-FILL will enable you to obtain accurate, high-quality imaging studies so you can make confi dent patient management decisions reliably and effi ciently.

Experience the RUBY-FILL Rubidium (Rb 82) Generators and Ruby Elution System Diff erence TODAY!

• Automated quality control for lab effi ciency• Engineered for user confi dence and effi ciency with a

30 liter volume and a long 60-day shelf life• Accurate patient specifi c infusion options including

constant-activity and weight-based dosing• Built-in safety controls to protect staff and patients

Contact your local sales representative to discuss business solutions tailored to YOUR needs or for more information visit www.draximage.com

Consider Your Choices

WARNING: UNINTENDED STRONTIUM 82 (Sr 82) AND STRONTIUM 85 (Sr 85) RADIATION EXPOSURE

Please see full prescribing information for complete boxed warning.

Unintended radiation exposure occurs when the levels of Sr 82 or Sr 85 in the Rubidium Rb 82 chloride injection exceed specifi c limits. Perform generator eluate tests: 1. Determine Rb 82, Sr 82, Sr 85 levels in the eluate:

• Once daily, prior to any drug administration, and• With additional daily tests after detection of an Alert Limit.

2. Stop use of the generator at its Expiration Limit.

Important Safety Information

Indication RUBY-FILL® Rubidium Rb 82 Generator is a closed system used to produce rubidium Rb 82 chloride injection for intravenous use. Rubidium Rb 82 chloride injection is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.

You are encouraged to report negative side eff ects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088. RUBY-FILL® is a registered trademark used under license by Jubilant DraxImage, Inc.

Jubilant DraxImage Inc.16751 Trans-Canada Highway, Kirkland, Quebec, Canada H9H 4J4Phone: 1.888.633.5343 / 514.630.7080 Fax: 1.866.431.4288 / 514.694.3865 www.draximage.com 2017CARD081

RUBY-FILL® Rubidium (Rb 82) Generator

ORGANIZING COMMITTEERob S.B. Beanlands, MD, FASNC, ChairFiras Al Badarin, MD, FASNCKarthikeyan Ananthasubramaniam,

MD, FASNCTimothy L. Dunn, CNMTDonna M. Polk, MD, MPH, FASNCRaymond R. Russell, MD, PhD, MASNCPrem Soman, MD, PhD, FASNC

PROGRAM COMMITTEESharmila Dorbala, MD, FASNC, ChairPanithaya Chareonthaitawee, MD,

Vice ChairMouaz Al-Mallah, MD, FASNCJames A. Arrighi, MD, MASNCFrank Bengel, MDRon Blankstein, MD, FASNCJamieson M. Bourque, MD, FASNCPaco Bravo, MDRenee Bullock-Palmer, MD, FASNCBenjamin Chow, MD, FASNCMarcelo Di Carli, MDVasken Dilsizian, MD, MASNCRami Doukky, MD, FASNCW. Lane Duvall, MDAndrew J. Einstein, MD, PhD, FASNCGabriel B. Grossman, MD, PhD, FASNCRory Hachamovitch, MD, FASNCMatthew E. Harinstein, MD, FASNCGary V. Heller, MD, PhD, MASNCMark C. Hyun, CNMT, NCT, RT(N), FASNCWael Jaber, MDNils P. Johnson, MDSaurabh Malhotra, MD, MPH, FASNCVenkatesh Murthy, MD, PhD, FASNCRobert A. Pagnanelli, CNMT, RT(N)(R),

FASNCDonna M. Polk, MD, MPH, FASNC Indu Poornima, MDTerrence D. Ruddy, MDRonald G. Schwartz, MD, MASNCMehran Sadeghi, MDMaria G. Sciammarella, MDNishant R. Shah, MD, MPH, FASNCAlbert J. Sinusas, MD, FASNC

Dear Colleagues,

I am delighted to invite you to the 23rd Annual Scientific Session of the American Society of Nuclear Cardiology, plus a celebration of ASNC’s 25th anniversary and the dynamic past, present and future of nuclear cardiology.

Please join us September 6-9 in San Francisco for a real-world edu-cational experience that reflects ASNC’s expertise as the only profes-sional organization dedicated to nuclear cardiology. ASNC2018 is designed by our field’s practitioners—a team of physicians, scientists,

technologists, and administrators—and the result is an up-to-date, specialized curriculum focused on the trends shaping daily clinical practice.

Personalized for You In this age of online educational content, the meetings I value most are the ones that help me get my hands on technologies and techniques that we’re not yet using in our practice. I love seeing what others are doing and bringing ideas back to our institution. ASNC2018 will give you that personalized experience, with hands-on reading sessions and opportunities to try out the latest innovations.

Focused on Real-world Practice Our litmus test for every ASNC2018 session was “Is it grounded in today’s, real-world practice?” As a result, you’ll find ASNC2018 sessions that break down challenges we’re all tackling, from MACRA, prior authorization and AUC requirements to how to modernize your SPECT lab, start a PET program, shop for a new scanner and compete for a job.

Collaborative & InteractiveASNC2018 also highlights the diversity of our community and the unique insights we all bring to optimizing patient care. You’ll interact with—

• Patients from the Amyloidosis Foundation, Stop Sarcoidosis Foundation, WomenHeart and more;

• Innovators from various healthcare disruptors, including IBM Watson, Google and Hewlett Packard;

• ASNC past presidents;

• Imaging society leaders discussing the “Value-Add” of specific studies and multimodal-ity approaches;

• And, of course, a diverse ASNC faculty

Starting Thursday, September 6 And, since it’s ASNC’s silver anniversary, we’re offering even more Annual Scientific Ses-sion for you to love! ASNC2018 will open at noon on Thursday, September 6, with a full educational lineup, including keynotes by Kim Allan Williams, MD, MASNC, and the Stanford WellMD Center’s Tait Shanafelt, MD.

Celebration of Nuclear Cardiology & ASNC We’re going to celebrate our specialty and our Society—and the tremendous value we bring to patients. ASNC2018 will be an educational feast and a wonderful fun time with friends and colleagues in one of the world’s best cities. I can’t wait to experience it with you. See you in San Francisco!

Sharmila Dorbala, MD, MPH, FASNC ASNC2018 Program Chair

Sharmila Dorbala MD, MPH, FASNC

Chair, ASNC18 Program Committee

Photo Credit: San Francisco Travel Association

for Positron Emission Tomography Myocardial Perfusion ImagingNuclear

Medicine Suite

In 1989, Bracco was the fi rst to invest heavily in cardiac PET MPI, and the legacy of excellence and service continues today.

£ Team of locally based, accessible clinical and accountspecialists, many with extensive experience usingCardioGen-82® (Rubidium Rb 82 Generator), supports you every step of the way.

£ Carefully developed and robust training protocols helpyou safely manage your patients.

£ Reimbursement professionals offer dedicated support,saving time for staff and patients.

The individuals shown are for illustrative purposes only. All persons depicted are models and not real patients/physicians.

Being fi rst matters.

CardioGen-82 (Rubidium Rb 82 Generator): Generating confi dence in cardiac PET for more than 25 years.

CardioGen-82 (Rubidium Rb 82 Generator) is a closed system used to produce rubidium Rb 82 chloride injection for intravenous administration. Rubidium Rb 82 chloride injection is indicated for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.

IMPORTANT SAFETY INFORMATION:WARNING: UNINTENDED STRONTIUM-82 (Sr-82) AND STRONTIUM-85 (Sr-85) RADIATION EXPOSURE

Unintended radiation exposure occurs when the levels of Sr-82 or Sr-85 in the rubidium Rb 82 chloride injection exceed specifi ed limits [see Warnings and Precautions (5.1)].Perform generator eluate tests: 1) Record each generator eluate volume, including waste and test volumes, and keep a record of the cumulative eluate volume [see Dosage and Administration (2.4)].2) Determine Rb-82, Sr-82, Sr-85 levels in the eluate:

• Once daily, prior to any drug administrations, and• At additional daily tests after detection of an Alert Limit. Alert Limits are:

14 L for the generator’s cumulative eluate volume, or An eluate Sr-82 level of 0.002 μCi/mCi Rb-82, or An eluate Sr-85 level of 0.02 μCi/mCi Rb-82.Perform the additional daily tests at time points determined by the day’s elution volume; tests are performed every 750 mL [see Dosage and Administration (2.5)].

3) Stop use of a generator at an Expiration Limit of: 17 L for the generator’s cumulative eluate volume, or 42 days post generator calibration date, or An eluate Sr-82 level of 0.01 μCi/mCi Rb-82, or An eluate Sr-85 level of 0.1 μCi/mCi Rb-82 [see Dosage and Administration (2.6)].

Pharmacologic induction of cardiovascular stress may be associated with serious adverse events such as myocardial infarction, arrhythmia, hypotension, bronchoconstriction, and cerebrovascular events. Perform pharmacologic stress testing in accordance with the pharmacologic stress agent’s prescribing information and only in the setting where cardiac resuscitation equipment and trained staff are readily available.You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/safety/medwatch, or call 1-800-FDA-1088.Please consult brief summary of the full Prescribing Information for CardioGen-82 (Rubidium Rb 82 Generator) including boxed WARNING on previous page. CardioGen-82 (Rubidium Rb 82 Generator) is manufactured for Bracco Diagnostics Inc., Monroe Township, NJ 08831, by GE Healthcare, Medi-Physics, Inc., South Plainfi eld, NJ 07080 CardioGen-82 is a registered trademark of, and We are Cardiac PET is a trademark of, Bracco Diagnostics Inc.Bracco Diagnostics Inc., 259 Prospect Plains Road, Building H, Monroe Township, NJ 08831 USAPhone: 609-514-2200 | Toll Free: 1-877-272-2269 (U.S. only) | Fax: 609-514-2446©2017 Bracco Diagnostics Inc. All Rights Reserved.

Visit www.cardiogen.com or call 1-877-BRACCO-9 (1-877-272-2269) to fi nd out what hundredsof cardiac care facilities and prestigious teaching institutions already know: We are Cardiac PET.™

CardiogenTrustAd_8.5x11_ASNC.indd 1 4/28/17 6:24 PM

CardiogenTrustAd_8.5x11_ASNC.indd 2 4/28/17 6:24 PM

ASNC’s 25th Anniversary Party

Celebrate!FRIDAY, SEPTEMBER 7

6:30 – 10:30 pm

Tickets $99 per person with advanced conference registration.

(Ticket price will increase to $125 onsite.)

Dinner | Complimentary Drink | Entertainment PLUS an ASNC 25th Anniversary Commemorative Tie-dye T-shirt

HIGHLIGHTS

www.asnc.org/ASNC2018

SPECIAL EVENTS

Additional Registration Required.

PET Satellite SessionSaturday, September 8, 6 – 8 pm, Implementing a Cardiac PET Program- The Why’s and How To’sCases with the AcesFriday, September 7, and Saturday, September 8, interactive cases that simulate scan interpretation in a small group, classroom setting (6 to choose from) Walk and Learn Tours with Past PresidentsFriday, September 7, and Saturday, September 8. Earn continuing education credits and explore fabulous San Francisco attractions while discussing new developments in nuclear cardiology with ASNC past presidents. Choose from Local Tastes of the City Food & Wine Tour and San Francisco Museum of Modern Art Tour (4 to choose from with 25-person limit each)

DON’T MISS

KEYNOTE SESSION Thursday, September 6, 12:00 pm

Finding Meaning, Balance and Professional Fulfillment in the Practice of MedicineTait Shanafelt, MD Director of the Stanford WellMD Center

THE MARIO VERANI LECTURE Thursday, September 6, 5:00 pm

Imaging in the Assessment of Preventive CardiologyKim Allan Williams, MD, MASNC, Professor, Rush University Medical Center

ARRIVE EARLY

SPACE LIMITED

With the future in mind, ASNC has established the Institute for the Advancement of Nuclear Cardiology (IANC) to catalyze and advance the field through research and innovation and the development of essential disciplines for the field.

Funded by the ASNC Fund, the IANC Research Award program was created to help individuals initiate a career in nuclear cardiology research and to assist new investigators in performing research that will add important new information to cardiac imaging literature.

I received a research grant from ASNC, which funded

my early work in left ventricular dyssynchrony assessment, and led

to the publication in Circulation: Cardiovascular Imaging, of the first

prospective study of nuclear-based dyssynchrony assessment in patients

undergoing cardiac resynchronization therapy. This seed funding at a critical stage

was an important catalyst for my career in nuclear cardiology.

Prem Soman, MD, PhD, FASNC President, ASNC Board of Directors

#ASNC2018 /myASNC @myASNC American Society of Nuclear Cardiology

WHAT’S NEW

• 25th anniversary celebratory events and opportunities

• Imaging-Based Case Management track led by master clinicians

• Elevating Patients’ Voices: Hear the perspectives of patients from the Amyloidosis Foundation, Stop Sarcoidosis, and WomenHeart

• Team-based Core Curriculum with nuclear cardiology teams presenting their best solutions to daily imaging challenges

• Deep-dives into machine learning, molecular imaging, and more fast-evolving innovations in nuclear cardiology

• Hands-on PET and SPECT simulation sessions

• Imaging society leaders will examine the value-add of specific studies and multimodality approaches

• Visit the Expo Hall to learn about the latest in nuclear cardiology technology and services

• And much more!

THE CHOOSING WISELY® CHALLENGE

SATURDAY, SEPTEMBER 8 4:00 – 5:30 pm Listen to live presentations by the three finalists and cast your vote to help the judging panel select the $3,000 top prize winner!View practice innovations and new technology solutions that support:• Implementation of appropriate use• Optimizing radiation dose• Enhanced communications with referring clinicians

ASNC thanks Bracco Diagnostics Inc. for support of the Nuclear Cardiology Choosing Wisely® Challenge.

Photo Credit: San Francisco Travel Association

ASNC EDUCATION

DisclosureASNC is pledged to ensure balance, independence, objectivity, and scientific rigor in all its supported educational activities through disclosure of relationships with commercial companies and resolution of conflict of interest. All planners, moderators, reviewers, and presenters involved with this activity are expected to disclose financial interests with the manufacturer(s) of any commercial product(s) and/or providers of commercial services discussed in an educational presentation. A complete list of disclosures will be distributed to all attendees on-site.

PROGRAM TRACKS

The program will include the following tracks to allow attendees to customize their educational experience.

PlenaryKeynote presentations from leaders in the field covering areas such as new technology and emerging clinical applications in nuclear cardiology.

Abstracts/ResearchPoster and oral abstract presentations, young investigator oral presentations, and sessions geared toward how to get your cardiovascular imaging research published.

AdvancedCutting-edge nuclear cardiology advances with a focus on clinical applications for these innovations.

Case-based Management (formerly RWTE)Master clinicians in cardiology explain how they use imaging to manage patients with complex cardiovascular diseases. Audience interaction is encouraged.

Cases with the Aces: Interactive Reading Small group sessions with faculty from premier nuclear cardiology training programs focused on scan interpretation using commercial software to simulate day-to-day imaging reading room experience. Audience participation is required.

Intersocietal Multimodality ImagingIntersocietal guidelines in nuclear cardiology and their clinical application to enable delivery of optimal patient care. Patient perspective is included.

PET Broad-based review of the clinical value of cardiac PET and its applications.

Special Sessions (non-track) These unique sessions offer educational walking tours, the latest applications of machine learning in imaging, ethical considerations, and physician well-being.

Team-based Learning (formerly Core)Global nuclear cardiology teams share creative solutions to practical day-to-day problems in clinical practice. Submit your questions to get answers to day-to-day nuclear cardiology problems. These sessions are geared towards the entire nuclear cardiology imaging team.

Technology and TechniquesInstructive sessions on nuclear cardiology procedures. Content is intended to provide practical information for providing quality imaging services. These sessions are geared towards the nuclear cardiology technologist.

Simulation LaboratoriesHands-on sessions in the Exhibit Hall focused on practical aspects of PET and SPECT imaging, including scanner selection, scanner quality assurance, generator elution, quantitative software use, and more. These sessions are geared towards the entire nuclear cardiology imaging team.

#ASNC2018 /myASNC @myASNC American Society of Nuclear Cardiologywww.asnc.org/ASNC2018

ACCREDITATION AND CONTINUING EDUCATION CREDIT

Physicians: This conference has been approved for 25.5* AMA PRA Category 1 CreditsTM.

Technologists: This conference has been approved for 23* ARRT Category A Credits.

Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditsTM from organizations accredited by ACCME.

Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCP) recognizes attendance at CE offerings which provide AMA PRA Category 1 CreditsTM for the purpose of recertification.

Maintenance of Certification Successful completion of this CME activity enables the participant to earn up to 20* Maintenance of Certification (MOC) points in the American Board of Internal Medicine’s (ABIM) MOC program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.*subject to change

TARGET AUDIENCE

This conference is intended for cardiologists, radiologists, nuclear medicine specialists, practice administrators, nuclear technologists, nurses, and other health care professionals with an interest in the field of nuclear cardiology and cardiac CT imaging.

Overall Purpose: The overall goal of the meeting is to improve learner knowledge, competence, and skill in appropriate use criteria, radiation safety, reporting, and lab performance in using appropriate guidelines-based treatment.

GENERAL LEARNING OBJECTIVES

• Demonstrate improved skills in image interpretation and reporting

• Learn how to recognize and minimize technical problems and artifacts that may be associated with cardiac imaging

• Learn the appropriate use of cardiac imaging techniques based on current guidelines

• Evaluate new imaging technologies, software, and stress techniques

• Understand the role of nuclear and cardiac CT imaging in overall patient care

• Learn the importance of balancing radiation exposure with image quality

• Describe future directions in cardiac PET, CT, and SPECT/CT in order to anticipate training and equipment needs

• Understand the clinical implication of CT coronary angiography and recognize its value and limitations in clinical cardiology

NUCLEAR CARDIOLOGYBoard Exam Preparation CourseSeptember 5 – 6, 2018 • San Francisco Marriott Marquis

REGISTER NOW

Earn up to 19* AMA PRA

Category 1 creditsTM and 19* MOC points

*subject to change

#ASNC2018 /myASNC @myASNC American Society of Nuclear Cardiology

PLENARY

Mario Verani Lecture: Imaging in the Assessment of Preventive Cardiology - Kim A. Williams, MD, MASNC

ASNC 25th Anniversary: Accomplishments, Recognition, and Moving Ahead• Video: ASNC Highlights and Achievements • ASNC President’s Lecture • JNC First and Current Editors’ Interviews • ASNC First and Current Presidents’ Interviews

Towards Molecular Cardiovascular Medicine - Emerging Opportunities for Non-invasive Imaging• The (Molecular and Cellular) Future of Cardiovascular Medicine from a

Translational Scientist’s Perspective• Explorer Project: Role of Whole Body PET Imaging of the

Cardiovascular System • Cardiovascular Molecular Imaging in Drug Development • President-Elect’s Address: What Will the Future Hold for Nuclear

Cardiology?

Frontiers in the Application of Nuclear Techniques• Advances in PET Perfusion and Flow Reserve • Advances in SPECT: Can it Rival PET for CAD Assessment? • Hybrid PET/MR Imaging to Better Characterize Pathophysiology of

Heart Disease• Nuclear Techniques in Infiltrative Diseases: Amyloid and Sarcoid

Imaging • PET Applications in Cardiac Implantable Device Infections and for

Guiding Arrhythmia Management

ADVANCED

Expanding the Horizon: Clinical Applications of New Tracers in Nuclear Cardiology• Cardiovascular Pathophysiology Targeted by Novel Tracers • Molecular Imaging of Aneurysm and Peripheral Arterial Disease • Sodium Fluoride Imaging of Coronary and Valvular Heart Disease • Imaging Device Thrombosis and DVT • Imaging Cardiac Inflammation Post Myocardial Infarction

Imaging to Guide Therapy: A Joint Session with EANM• Arrhythmia and Dyssynchrony • Vasculitis• Cardiotoxicity• Theranostics in Cardiovascular Medicine

What’s New in Instrumentation: Hardware and Algorithms• Pre-clinical Instrumentation • Image Reconstruction and Analysis • Advances in Clinical Instrumentation: SPECT • Advances in Clinical Instrumentation: PET and PET/MRI

CASES WITH THE ACES

• Bread and Butter Nuclear Cardiology Cases from Brown University• SPECT and SPECT/PET (Jefferson Heart Institute)• Analysis, Interpretation, and Reporting of PET-CFR (Brigham &

Women’s Hospital)• A Day in the Life of the Ottawa Heart Institute Nuclear Laboratory, MPI

PET, SPECT, and FDG PET Imaging• SPECT and Nuclear Cardiology Cases from Mayo Clinic• SPECT and PET Cases of all Kinds from Yale University

IMAGING-BASED CASE MANAGEMENT (RWTE)Ischemic Heart Disease: Complex CasesEach topic will have a case presentation followed by an imaging discussion followed by a general discussion.• The Obese Patient with Suspected CAD• The High Risk/Complex CAD Patient• The Patient Presenting Late after a MI

Heart Failure: Pump in a SlumpEach topic will have a case presentation followed by an imaging discussion followed by a general discussion. Session will include a patient interview.• A Patient with New Onset Non-ischemic Cardiomyopathy • A Patient with Chemo/Radiation Therapy • A Patient with Prior Cardiac Transplantation

Heart Disease in Women: The Heart TruthEach topic will have a case presentation followed by an imaging discussion followed by a general discussion.• Patient Interview• Coronary Microvascular Dysfunction • Spontaneous Coronary Artery Dissection • Chest Pain in a Patient with Rheumatological Illness

Chest Pain Evaluation (Multimodality): The Elephant on my ChestEach topic will have a case presentation followed by an imaging discussion followed by a general discussion.• Emergency Room Patient • Outpatient with Chest Pain • Young Patient with CAD INTERSOCIETAL MULTIMODALITY IMAGING

What is New in CAC Scoring in 2018: Implications for Nuclear Cardiologists (Joint Session with SCCT)• Update on Use of CAC Scoring in Preventive Cardiology • How to Manage Patients with Elevated CAC Score ... When is Further

Testing Needed • Role of CAC Testing in Low Risk Chest Pain Patients • What is the Role of Adding CAC to SPECT and PET Myocardial

Perfusion Imaging?

Cardiac Sarcoidosis: Evolving Imaging Algorithms for an Evolving Disease This session is supported by an educational grant from Advanced Accelerator Applications, a Novartis company.• Patient Interview • Cardiac MRI and Echocardiography: Screening, Diagnosis and

Prognosis per the Guidelines • PET for Cardiac Sarcoidosis: Robust Test in the Right Hands and

Patients per the Guidelines • Putting it all Together: Evaluation and Management of Sarcoidosis in

the Real World

Multisocietal Consensus Recommendations on Imaging in Cardiac Amyloidosis Imaging• Patient Interview • Pathogenesis • Diagnostic Criteria and Appropriate Use in Cardiovascular Imaging • Echo/CMR Imaging • PYP/DPD Imaging • Key Clinical Questions and Optimal Management of Cardiac

Amyloidosis

PROGRAM SCHEDULE

#ASNC2018 /myASNC @myASNC American Society of Nuclear Cardiologywww.asnc.org/ASNC2018

Multimodality Evaluation of Infective Endocarditis: Moving Beyond Echocardiography (Joint Session with EANM)• Case Presenter • Role of Echocardiography in Infective Endocarditis: Limitations, Pitfalls,

and New Techniques• MSCT: Is it Important Just for Complicated Cases? • What is the Role of Adding PET/CT to Echocardiogram? • What is the Role of Imaging Techniques in Both the Diagnosis and

Management of Infective Endocarditis? Clinical Point of View

PET

Incorporating Myocardial Blood Flow Quantification with PET/CT into Practice• How do I Know the Number is Right - Technical Aspects • When and How to Report Myocardial Blood Flow • PET MBF and CAC Score: Complementary or Contradictory? • FFR, iFR, MFR - Do they all Provide the Same Information?

PET Controversies• Debate 1:

- Breakthrough - Multiparametric Quantitative PET/CT Myocardial Perfusion Approach for Detection of Coronary Artery Disease

- Controversy 1 - What Would it Take for Cardiac PET/CT to Replace SPECT MPI for CAD Evaluations?

- Controversy 2 - Will MRI Perfusion and Quantitative Blood Flow Replace PET?

• Debate 2: - Breakthrough - Quantitative PET Evaluation of Myocardial Viability - Controversy 1 - Is it Necessary for Guiding Revascularization

Decisions? - Controversy 2 - MRI Assessment of Myocardial Viability: Is PET No

Longer Needed?

When is PET a Better Choice than SPECT?A case-based session designed to educate people on when PET may be a better choice than SPECT.

TEAM-BASED LEARNING (CORE)

How to Optimize Your PET Lab• Patient Selection to Leverage Advantages of Cardiac PET • Cardiac PET Protocols: Experience from Diverse Practices • Recognition of PET Artifacts • How to Approach Incidental Findings in Cardiac PET

Best Practices to Optimize Radiation Dose (Joint Session with IAEA)• International Perspective• U.S. Perspective• Technologist Perspective• Physicist Perspective

How to Optimize Your SPECT Lab: An Imaging Team ApproachHow to optimally manage daily nuclear cardiology workflow. Overcoming Barriers. Why are we still debating about one-day Tc-99m protocol rest/stress? Attenuation correction and other emerging technology in SPECT3. Benefits of using CZT stress/rest MPI. Practical Dilemmas - bring your questions, take home solutions.

Maximize Risk Assessment in Exercise Myocardial Perfusion Imaging• ECG Findings Beyond ST Segment Changes • Role of Quantitative Perfusion Assessment for Risk Stratification • Putting It All Together: Risk Assessment in Challenging Cases with

Discordant Information, including CT • How will Machine Learning Enhance our Image Interpretation?

TECHNOLOGY AND TECHNIQUES

SPECT QAFocused on DSPECT; DNN530; IQ-SPECT

The Importance of Quality in Nuclear Cardiology - What is the Technologist’s Role? Part I

The Importance of Quality in Nuclear Cardiology - What is the Technologist’s Role? Part II

SPECIAL

Physician Well-being and its Implications for Quality of Care• Finding Meaning, Balance and Professional Fulfillment in the Practice

of Medicine – Tait D. Shanefelt, MD, Stanford WellMD Center

Machine Learning, Medicine, and Imaging: The Future is Now• Martin C. Stumpe, PhD, Google• Piotr J. Slomka, PhD, Cedars Sinai Medical Center• Puneet Sharma, PhD, Hewlett Packard• Alok Gupta, PhD, MBA, IBM Watson Health Imaging• Fabien Beckers, PhD, Arterys Medical Imaging Cloud AI

Ethics Session: The Role of Radiology Benefits Managers and Physician Decision Support Tools in Cardiac ImagingCase presentation followed by panel and audience interaction.

Contemporary Evaluation and Management of Cardiac Amyloidosis (Joint Session with HFSA)Case-based session focused on reviewing many recent advances in the evaluation and management of cardiac amyloidosis, an entity that heart failure clinicians are likely to see more in the coming years. Topics to be covered: Nosology/Epidemiology/Clinical Challenges; Diagnosis (Imaging, Biomarkers, Biopsy); Contemporary Therapeutics; Knowledge Gaps; Future Directions

Taste of the City Walking Tour with ASNC Past Presidents – Friday and SaturdayHow to Develop, Promote, Sustain, and Maintain a Cardiac Imaging Service: Focus on Optimal Use of Imaging and Appropriate Use

San Francisco MOMA Walking Tour with ASNC Past Presidents – Friday and Saturday• Modern Art/The Art of Social Media in Imaging (Friday)• Modern Art/Contemporary SPECT (Saturday)

Population Health and Health Policy• AUC Implementation and Advocacy Efforts • MIPS/ MACRA Year Three Changes• Coding for New Technology

Registry Update• National Multimodality Perspective on Registries

- Impact on Clinical Activities - MIPS/QCDR and Quality/Accreditation - Impact on Directing Care and Guidelines for the Future

• ImageGuide – Today and Tomorrow

Alliance of Cardiac Subspecialty Organizations: What Have We Learned from Nuclear Cardiology?

#ASNC2018 /myASNC @myASNC American Society of Nuclear Cardiology

Brian G. Abbott, MD, MASNCCardiovascular Inst. RI and Miriam HospEast Greenwich, RI

Omar F. Abouezzeddine, MDCMMayo ClinicRochester, MN

Niti R. Aggarwal, MD, FASNCUW HealthMadison, WI

Kevin M. Alexander, MDStanford University Medical CenterStanford, CA

Erick Alexanderson, MDInstituto Nacional de CardiologiaMexico City, Mexico

Ahmed Aljizeeri, MB BSAbdul-Aziz Cardiac CenterRiyadh, Saudi Arabia

Mouaz H. Al-Mallah, MD, MSc, FASNCKing AbdelAziz Cardiac CenterRiyadh, Saudi Arabia

Karthikeyan Ananthasubramaniam, MD, FASNCHenry Ford HospitalDetroit, MI

Andrew E. Arai, MDNational Institutes of HealthBethesda, MD

James A. Arrighi, MD, MASNCRhode Island HospitalProvidence, RI

Parthiban Arumugam, MB BSManchester Royal InfirmaryManchester, United Kingdom

Larry M. Baddour, MDMayo ClinicRochester, MN

Lauren A. Baldassarre, MDYale Cancer CenterNew Haven, CT

Timothy M. Bateman, MD, MASNCSt. Luke’s Mid America Heart InstituteKansas City, MO

Rob S.B. Beanlands, MD, FASNCUniversity of OttawaOttawa, ON Canada

Fabien Beckers, PhDArterysSan Francisco, CA

George A. Beller, MD, MASNCUniversity of Virginia Health SystemCharlottesville, VA

Frank Bengel, MDMedizinische Hochschule HannoverHannover, Germany

Daniel S. Berman, MD, MASNCCedars-Sinai Medical CenterLos Angeles, CA

Ron Blankstein, MD, FASNCBrigham & Women’s HospitalBoston, MA

Robert Bober, MDOchsner Heart and VascularNew Orleans, LA

John Bois, MDMayo ClinicRochester, MN

Sabahat Bokhari, MD, FASNCColumbia University Medical CenterGreen Brook, NJ

Elias H. Botvinick, MDUCSF Department of MedicineSan Francisco, CA

Jamieson M. Bourque, MD, FASNCUniversity of Virginia Health SystemsCharlottesville, VA

Paco E. Bravo, MDUniversity of WashingtonSeattle, WA

Ralph G. Brindis, MDUniv. of CA San FranciscoSan Francisco, CA

Renee Bullock-Palmer, MD, FASNCDeborah Heart and Lung HospitalBrowns Mills, NJ

Dennis A. Calnon, MD, MASNCOhioHealth Heart & Vasc PhysiciansColumbus, OH

Manuel D. Cerqueira, MD, MASNCCleveland Clinic FoundationCleveland, OH

Panithaya Chareonthaitawee, MDMayo ClinicRochester, MN

Simon R. Cherry, PhDUC DavisDavis, CA

Benjamin Chow, MD, FASNCUniversity of Ottawa Heart InstituteOttawa, ON Canada

Paul Cremer, MDCleveland Clinic FoundationShaker Heights, OH

Sarah Cuddy, MB ChBBrigham & Women’s HospitalBoston, MA

Robert A. deKemp, PhDUniversity of Ottawa Heart InstituteOttawa, ON Canada

Ernest G, DePuey, MD, MASNCMount Sinai St. Luke’s HospitalNew York, NY

Marcelo Di Carli, MDBrigham & Women’s HospitalBoston, MA

Joseph Dietz, CNMTUPMC Cardiovascular InstitutePittsburgh, PA

Vasken Dilsizian, MD, MASNCUniv Maryland Med CtrBaltimore, MD

Sharmila Dorbala, MD, FASNCBrigham and Women’s HospitalBoston, MA

Rami Doukky, MD, FASNCCook County Health and Hospitals SystemChicago, IL

Timothy L. Dunn, CNMTMaine Cardiology AssociatesS. Portland, ME

W. Lane Duvall, MDHartford HospitalHartford, CT

Andrew J. Einstein, MD, PhD, FASNCColumbia University Medical CenterNew York, NY

Georges El Fakhri, PhDHarvard Medical SchoolBoston, MA

Barry Elison, MB, BSWollongong HospitalWollongong, NSW Australia

Kathleen Flood American Society of Nuclear CardiologyBethesda, MD

Oliver Gaemperli, MDUniversity Hospital ZurichZurich, Switzerland

James R. Galt, PhDEmory University School of MedicineAtlanta, GA

Ernest V. Garcia, PhD, MASNCEmory University HospitalAtlanta, GA

Myron C. Gerson, MD, MASNCUniversity of Cincinnati Medical CenterCincinnati, OH

Henry Gewirtz, MDMassachusetts General HospitalCambridge, MA

Raymond J. Gibbons, MD, MASNCMayo ClinicRochester, MN

Robert J. Gropler, MD, MASNCWashington UniversitySt. Louis, MO

Gabriel B Grossman, MD, PhD, FASNCHospital Moinhos de VentoPorto Alegre, Brazil

Alok Gupta, PhD, MBAIBM WatsonCambridge, MA

Rory Hachamovitch, MD, FASNCCleveland Clinic FoundationCleveland, OH

Marcus Hacker, MDAllgemeines Krankenhaus WienVienna, Austria

Christopher L. Hansen, MD, FASNCJefferson Heart InstitutePhiladelphia, PA

Matthew E. Harinstein, MD, FASNCUniv. of Pittsburgh Medical CenterPittsburgh, PA

Gary V. Heller, MD, PhD, MASNCMorristown Medical CenterNew Haven, CT

Robert C. Hendel, MD, MASNCTulane Univ. School of MedicineNew Orleans, LA

Thomas A. Holly, MD, FASNCNorthwestern UniversityChicago, IL

Edward Hulten, MD, MPH, FASNCWalter Reed National Military Medical CenterBethesda, MD

Fabien Hyafil, MD, PhDHopitaux de ParisParis, France

Mark C. Hyun, CNMT, NCT, RT(N)(R), FASNCCedars-Sinai Medical CenterLos Angeles, CA

Andrei Iagaru, MDStanford University Medical CenterStanford, CA

Ami E. Iskandrian, MD, PhD, MASNCUniversity of Alabama at BirminghamBirmingham, AL

Wael A. Jaber, MDCleveland Clinic FoundationCleveland, OH

Diwakar Jain, MD, MASNCWestchester Medical CenterValhalla, NY

Scott D. Jerome, DO, FASNCUniversity of Maryland School of MedicineWestminster, MD

Lynne L. Johnson, MDColumbia UniversityNew York, NY

Nils P. Johnson, MDUniversity of Texas Medical School at HoustonHouston, TX

Hayan Jouni, MDMayo ClinicRochester, MN

Denise Kale, CNMTSNJCS-Cooper Heart InstituteVoorhees, NJ

Philipp A. Kaufmann, MDUniversity Hospital ZurichZurich, Switzerland

Juhani Knuuti, MD, PhDUniversity of TurkuTurku, Finland

Gregory Lanza, MD, PhDWashington UniversitySt. Louis, MO

Georgia Lawrence Hearn, JDAmerican Society of Nuclear CardiologyBethesda, MD

Jeffrey A. Leppo, MD, MASNCBerkshire Medical CenterPittsfield, MA

INVITED FACULTY(as of press time)

#ASNC2018 /myASNC @myASNC American Society of Nuclear Cardiologywww.asnc.org/ASNC2018

Ronglih Liao, PhDBrigham & Women’s HospitalBoston, MA

Maria L. Mackin, CNMT, RT, RT(N)University of RochesterRochester, NY

Jamshid Maddahi, MD, FASNCDavid Geffen School of Medicine at UCLALos Angeles, CA

John J. Mahmarian, MD, MASNCMethodist DeBakey Cardiology AssociatesHouston, TX

Saurabh Malhotra, MD, MPH, FASNCUniversity of BuffaloBuffalo, NY

April Mann, MBA, CNMT, RT(N), NCT, MASNCHartford HospitalHartford, CT

Gregary Marhefka, MDJefferson Heart InstitutePhiladelphia, PA

Ahmad Masri, MDUniversity of Pittsburgh Medical CenterPittsburgh, PA

Jeffrey Meden, CNMT, FASNCUniversity of MichiganAnn Arbor, MI

Rupa Mehta Sanghani, MD, FASNCRush University Medical CenterChicago, IL

Venu Menon, MDCleveland Clinic FoundationCleveland, OH

Denise A. Merlino, CPC, MBA, CNMTMerlino Healthcare Consulting Corp.Gloucester, MA

Jennifer H. Mieres, MD, MASNCNorth Shore — Long Island Jewish Health SystemLake Success, NY

Edward J. Miller, MD, PhD, FASNCYale UniversityNew Haven, CT

Todd D. Miller, MD, MASNCMayo ClinicRochester, MN

Jereme Morley, CNMTMount Sinai St. Luke’s HospitalNew York, NY

Venkatesh L. Murthy, MD, PhD, FASNCUniversity of MichiganAnn Arbor, MI Fernando Mut, MDSpanish Association HospitalMontevideo, Uruguay

Kenichi Nakajima, MD, PhDKanazawa University HospitalKanazawa, Japan

Khurram Nasir, MD, MPHYale School of MedicineNew Haven, CT

Danilo Neglia, MD, PhDFondazione Toscana Gabriele MonasterioPisa, Italy

Stephan Nekolla, PhDTech-nische Universität MünchenMunchen, Germany

Diana Paez, MDInternational Atomic Energy AgencyVienna, Austria

Robert A. Pagnanelli, CNMT, RT(N)(R), NCT, FASNCDuke University Medical CenterDurham, NC

Shivda Pandey, MDBoston Medical CenterBoston, MA

Amit R. Patel, MDUniversity of ChicagoChicago, IL

Lawrence M. Phillips, MD, FASNCNYU School of MedicineNew York, NY

Donna M. Polk, MD, MPH, FASNCBrigham & Women’s HospitalBoston, MA

Indu Poornima, MDAllegheny General HospitalPittsburgh, PA

C. Christina Quarta, MD, PhD University College of LondonLondon, UK

Jeffrey A. Rosenblatt, MD, FASNCMaine Health CardiologySouth Portland, ME

Frederick L. Ruberg, MDBoston University School of MedicineBoston, MA

Terrence D. Ruddy, MDUniversity of Ottawa Heart InstituteOttawa, ON Canada

Raymond R. Russell, III, MD, PhD, MASNCRhode Island HospitalProvidence, RI

Mehran Sadeghi, MDYale UnviersityNew Haven, CT

Ibrahim M. Saeed, MDSt. Luke’s Mid America Heart InstituteKansas City, MO

Michael Salerno, MDUVA Heart and Vascular CenterCharlottesville, VA

Walid Saliba, MDClevaland Clinic FoundationCleveland, OH

Heinrich R. Schelbert, MD, PhDUCLA School of MedicineLos Angeles, CA

Thomas H. Schindler, MDJohns Hopkins UniversityBaltimore, MD

Ronald G. Schwartz, MD MS, MASNCUniversity of Rochester Medical CenterRochester, NY

Maria G. Sciammarella, MDUniversity of CaliforniaSan Francisco, CA

Amil M. Shah, MDStanford University Medical CenterStanford, CA

Nishant Shah, MD, MPHAlpert Medical School of Brown UniversityProvidence, RI

Tait D. Shanafelt, MDStanford School of MedicineStanford, CA

Puneet Sharma, PhDHewlett PackardPalo Alto, CA

Leslee J. Shaw, PhD, MASNCEmory Univ Sch MedAtlanta, GA

Albert J. Sinusas, MD, FASNCYale University School of MedicineNew Haven, CT

Hicham Skali, MDBrigham & Women’s HospitalBoston, MA

Reimer H.J.A. Slart, MDUniversity Medical CenterGroningen, Netherlands

Piotr J. Slomka, PhDCedars-Sinai Medical CenterLos Angeles, CA

Gary R. Small, MDOttawa Heart InstituteOttawa, ON

Prem Soman, MD, PhD, FASNCUPMC Heart and Vascular InstitutePittsburgh, PA

Martin C. Stumpe, PhDGoogleMountain View, CA

Viviany R. Taqueti, MDBrigham and Women’s HospitalBoston, MA

Gregory S. Thomas, MD, MPH, MASNCLong Beach Memorial Medical CenterLong Beach, CA

Randall C. Thompson, MD, FASNCSt Luke’s Mid America Heart InstituteKansas City, MO

Peter Tilkemeier, MD, FASNCGreenville Health SystemGreenville, SC

Julius Torelli, MDeviCore HealthcareFranklin, TN

Mark I. Travin, MD, MASNCMontefiore Medical CenterPleasantville, NY

Vera Tsatkin, CNMTYale New Haven HospitalNew Haven, CT

James E. Udelson, MD, MASNCTufts-New England Medical CenterBoston, MA

William A. Van Decker, MD, MASNCTemple University HospitalPhiladelphia, PA

Vikas Veeranna, MDBerkshire Medical CenterPittsfield, MA

Hein J. Verberne, MD, PhDAcademic Medical CenterAmsterdam, Netherlands

João Vitola, MD, PhD, MASNCQuanta Diagnostico & TerapiaCuritiba, Brazil

Frans J. Wackers, MD, PhD, MASNCYale UniversityNew Haven, CT

L. Samuel Wann, MDCSM CardiologyMilwaukee, WI

Jaime Warren, CNMT, MBANorton HealthcareLouisville, KY

Janet Wei, MDCedars SinaiLos Angeles, CA

Richard Weinberg, MD, PhDUniversity of MichiganAnn Arbor, MI

R. Glenn Wells, PhDUniversity of Ottawa Heart InstituteOttawa, ON Canada

Kim A. Williams, MD, MASNCRush University School of MedicineChicago, IL

David E. Winchester, MD, FASNCUniversity of FloridaGainesville, FL

Ronald Witteles, MDStanford Health CareStanford, CA

David G. Wolinsky, MD, MASNCCleveland Clinic FloridaWeston, FL

Joseph C. Wu, MD, PhDStanford University School of MedicineStanford, CA

Barry L. Zaret, MD, MASNCYale Univ. School of MedicineNew Haven, CT

#ASNC2018 /myASNC @myASNC American Society of Nuclear Cardiology

Book travel now to ensure you will arrive in time for the full educational program, starting September 6, 2018, at noon.

Registration FeesTo qualify for the Early Bird Registration rate, registration must be submitted, along with payment by July 9, 2018. Pre-registration rates are in effect from July 10 through August 23, 2018. After August 23, 2018 interested par-ticipants must pay the on-site registration rate. Register online by going to asnc.org/ASNC2018 or use the registra-tion form on page 15.

CancellationsNotification of cancellation must be received in writing. Send to: asnc@conferencedirect.com by August 23, 2018 to receive a refund minus a $75 administrative fee. Please allow three weeks for processing. Telephone cancellations are not eligible for a refund, and no refunds will be is-sued after August 23, 2018.

Americans With Disabilities ActASNC supports the Americans with Disabilities Act. If you have a disability for which you may require an auxiliary aid or special service, contact annualmeeting@asnc.org by August 30, 2018.

HousingSan Francisco Marriott Marquis780 Mission StreetSan Francisco, CA 94103Room Rates – Single/Double $239.00/night

To receive the negotiated group rate, you must make your reservations through the ASNC2018 Housing Bureau which can be accessed at asnc.org/ASNC2018. Make your reservations early to ensure space at the San Francisco Marriott Marquis. The deadline for guaranteed rates is August 12, 2018. Rates shown do not include occupancy tax currently at 16.25% + $.75 per room per night.

Room Deposit PolicyAll reservations require a deposit of one night’s room and tax. Reservations cannot be processed without a deposit. If paying by credit card, the deposit may be reflected on your credit card statement as early as August 13, 2018 (subject to change). The deposit will appear on your hotel room folio at check-in.

Modifications and CancellationsAll reservation modifications and cancellations must be made through the ASNC2018 Housing Bureau and are to be received by August 12, 2018. After August 12, 2018, contact the hotel directly for new reservations, modifica-tions and cancellations. Please note that there is a $50.00 hotel cancellation fee that will be processed immediately after cancellation.

Cancellations must be made 72 hours prior to your arrival for refund of your one night’s room and tax deposit. Failure to check in on the scheduled date of arrival will result in the loss of one night’s room and tax and cancellation of reservation. A fee may be assessed for early departures.

Official Housing BureauThe official ASNC2018 Housing Bureau (Conference Direct) requires one night’s room and tax deposit to secure hotel room reservations. Any other company requiring deposits or full prepayment should be viewed with ex-treme suspicion, if they falsely imply they are affiliated with ASNC2018. This could result in attendees arriving with no reservations and no recourse for the payment of rooms.

#ASNC2018 /myASNC @myASNC American Society of Nuclear Cardiology

Questions? asnc@conferencedirect.com or 888-980-8836.

REGISTRATION AND HOTEL

NAME WITH DEGREE(S)

INSTITUTION

ADDRESS CITY/ STATE/ ZIP/ COUNTRY

PHONE FAX E-MAIL

As a Member you can save up to $300 on your ASNC2018 registration. Renew or Join at www.asnc.org/joinasncPayment must accompany this form. Make check payable to ASNC in U.S. funds Method of Payment: o CHECK o AMEX o MASTERCARD o VISA

CARD # EXPIRATION DATE CVC/ SECURITY CODE

PRINT NAME ON CARD SIGNATURE

Early Bird Registration Pre-registration(By July 9, 2018) (July 10 – August 23, 2018)Member Non-Member Member Non-Member

Annual Meeting and Board Prep Program o Physician $1129 $1429 $1229 $1529o Physician (Gold Registration – includes BP Meeting on Demand) $1528 $1878 $1628 $1978o Fellows in Training*/IEM $829 $1029 $929 $1129o Fellows in Training*/IEM (Gold Registration – includes BP Meeting on Demand) $1078 $1328 $1178 $1428

Annual Meeting Onlyo Physician $729 $1029 $829 $1129o Other† $349 $449 $349 $449 † Please select one “Other” category o Technologist o Nurse o Fellow* o Industry o Scientist o Practice Administrator o International Emerging Markets

Board Exam Preparation Course only o Physician $929 $1229 $1029 $1329o Physician (Gold Registration – includes Meeting on Demand) $1328 $1678 $1428 $1778o Fellows*/IEM $669 $869 $769 $ 969o Fellows*/IEM (Gold Registration – includes Meeting on Demand) $918 $1168 $1018 $1268

Board Prep Syllabus (Board Prep attendees must choose one)o Electronic Syllabus $0 $0 $0 $0o Color printed syllabus plus electronic syllabus $225 $225 $225 $225

25th Anniversary Celebration Party (Friday, 6:30-10:30pm) T-shirt Size o S o M o L o XL $99 $99 $99** $99**

Cases with the Aces ($25 per session – max 2.) o Brigham & Women’s o Yale o Mayo Clinic o Brown o Jefferson Heart o Ottawa Heart Inst. ___ X $25 No more than 2

Walking Tours – each tour will include continuing medical education for physicians. Food Tour $100 (includes food and drink) $100 $100 $100 $100o Friday (1:30-4:30pm) o Saturday (1:30-4:30pm)

San Francisco Museum of Modern Art Tour (includes box lunch and ticket to museum) o Friday (10:15am-12:45pm) o Saturday (10:15am-12:45pm) $75 $75 $75 $75

TOTAL PAYMENT: $__________________________

THREE EASY WAYS TO REGISTER FOR ASNC2018:1. Online: www.asnc.org/ASNC20182. Fax: (704) 927-1439

Credit card payments only3. Mail: ASNC

4340 East-West Highway Suite 1120 Bethesda, MD 20814

After August 23, 2018 registrations will be charged at the on-site registration rate.Please note that the on-site registration fee is an additional $100 for all registration categories.

Annual Scientific Session of the American Society of Nuclear Cardiology

September 6-9, 2018 Marriott Marquis, San Francisco, California

REGISTRATION FORM

* Verification of fellow status from training director required for all fellow non-members** 25th Anniversary Celebration Party tickets purchased on-site will cost $125

Register and book your hotel online – www.asnc.org/asnc2018

American Society of Nuclear Cardiology4340 East West Highway, Suite 1120 Bethesda, MD 20814-4578

NON-PROFITORGANIZATIONU.S. POSTAGE

PAIDBETHESDA, MD

PERMIT NO. 4114

www.asnc.org/ASNC2018

NETWORK WITH COLLEAGUES

SEE THE LATEST TECHNOLOGY

EARN CME/CES

Registration and Hotel Important Dates - Mark Your Calendar

� Early bird registration deadline: Monday, July 17

� Hotel booking deadline: Thursday, August 24

� Advance registration deadline: Thursday, August 31

Venue Sheraton Kansas City Hotel

at Crown Center

2345 McGee Street

Kansas City, MO 64108

Exhibit and Sponsor Opportunitieswww.asnc.org/asnc2017exhibitor

Contact Leanne Cardwell at lcardwell@asnc.org

#ASNC2018

ASNC Prelim Program-2017-�nal-�nal.indd 16 5/16/17 4:42 PM

Registration and Hotel

ASNC2018Annual Scientific Session

September 6-9, 2018 San Francisco, CaliforniaSan Francisco Marriott Marquis

American Society of Nuclear Cardiology

Important Dates - Mark Your Calendar

✔ Abstract submissions deadline – April 6, 2018

✔ Early bird registration deadline – July 9, 2018

✔ Hotel booking deadline – August 13, 2018

✔ Advance registration deadline – August 23, 2018

VenueSan Francisco Marriott Marquis

780 Mission St.

San Francisco, CA 94103

Exhibit and Sponsor Opportunitieswww.asnc.org/asnc2018exhibitor

Contact Leanne Cardwell at Lcardwell@asnc.org

Absolute Imaging SolutionsAmerican College of

Radiology (ACR)Amyloidosis Foundation

APCAAstellas Pharma US, Inc.Bracco Diagnostics, Inc.

Cardiovascular Imaging Technologies (CVIT)

CDL Nuclear TechnologiesCedars-Sinai Medical Center

DigiradGE Healthcare

Intersocietal Accreditation Commission

INVIA Medical Imaging Solutions

IonetixJubilant Draximage Inc

Lantheus Medical Imaging Inc.

Japanese Society of Nuclear Medicine

McGraw-Hill EducationMedTrace

MiE America IncMIM Software

Modern NuclearMolecular Imaging Services

Nuclear Medicine Technology Certification Board

Nuclear Imaging Services, LLC

Philips HealthcareScImage, Inc.

Siemens HealthineersSociety of Nuclear Medicine

and Molecular ImagingSouthwestern Imaging

Systems & ServiceSpectrum Dynamics

Medical Inc.Subtle Medical, Inc.

SyntermedThinking Systems Corporation

Wolters Kluwer

ASNC would like to thank the following exhibitors for their generous support as of press time